2013
DOI: 10.1056/nejmc1303656
|View full text |Cite
|
Sign up to set email alerts
|

Esophageal Sphincter Device for Gastroesophageal Reflux Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 23 publications
0
6
0
1
Order By: Relevance
“…Zur Beurteilung der Methode stehen zahlreiche prospektive und retrospektive Kohortenstudien, eine prospektiv randomisierte Studie mit dem Vergleich zu einer Doppeldosis Protonenpumpeninhibitoren (PPI) wie auch einige nicht randomisierte Studien im Vergleich zur laparoskopischen Fundoplikation zur Verfügung [9 -13]. Zwei größere Metaanalysen fassen die Ergebnisse zusammen [14,15].…”
Section: Magnetische Sphinkteraugmentation (Msa)unclassified
“…Zur Beurteilung der Methode stehen zahlreiche prospektive und retrospektive Kohortenstudien, eine prospektiv randomisierte Studie mit dem Vergleich zu einer Doppeldosis Protonenpumpeninhibitoren (PPI) wie auch einige nicht randomisierte Studien im Vergleich zur laparoskopischen Fundoplikation zur Verfügung [9 -13]. Zwei größere Metaanalysen fassen die Ergebnisse zusammen [14,15].…”
Section: Magnetische Sphinkteraugmentation (Msa)unclassified
“…After one year follow-up, patients were reported to be off PPIs in 25% of cases. EsophyX offers advantages over surgery [14][15][16][17], in particular the absence of incision and thus a faster remission, as well as fewer complications in the short and long term compared to the undesirable side effects associated with laparoscopic anti-reflux procedure compromising the results in some patients. Currently published literature suggests that incidence of persistent side effects after TIF is low [4][5][6].…”
Section: Discussionmentioning
confidence: 99%
“…The magnetic union between each of the beads allows the passage of the swallowed bolus but inhibits the reflux of stomach contents into the esophagus 5 ( Figure 1 ). Although several studies have demonstrated the safety and efficacy of the device 3 - 5 , 7 , 10 - 14 , 16 , 19 , 20 , 23 , 25 , 26 , 29 , 32 - 34 , 40 , 41 , 43 , 45 , 46 , 48 - 50 , 52 , 55 , large series and randomized trials supporting its use are still lacking.…”
Section: Introductionmentioning
confidence: 99%